GlaxoSmithKline Pharma Q1 Results | Net profit posts healthy growth led by Calpol, T-Bact, other key brands
GlaxoSmithKline Pharma Q1 Results | The global healthcare company reported a 37.8% year-on-year (YoY) jump in net profit at ₹182.3 crore, with EBITDA soaring 60.1% to ₹230.6 crore. Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,824.45, up by ₹68.55, or 2.49%, on the BSE…
GlaxoSmithKline Pharma Q1 Results | The global healthcare company reported a 37.8% year-on-year (YoY) jump in net profit at ₹182.3 crore, with EBITDA soaring 60.1% to ₹230.6 crore. Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,824.45, up by ₹68.55, or 2.49%, on the BSE…
Read More
About Author
